EZH2 and neoplasm: Interestingly, the combination treatment exhibited a dramatic anti-tumor effect in EZH2 wild-type and mutant CDX and PDX xenograft models, demonstrating the potential synergistic anti-tumor effect of the two drugs in vivo.